483 Changzhou Sunlight Pharmaceutical Sep 2017

483 Changzhou Sunlight Pharmaceutical Sep 2017

Cheryl Clausen FDA$119.00 - Available Now

FDA investigators audited the Changzhou Sunlight Pharmaceutical - Changzhou, China facility and issued inspectional observations (via FDA 483) on 22 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Sep 2017
  • Location: Changzhou, China
  • FEI: 3003662818
Add To Cart